Quality of life and cognitive dysfunction in people with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 1, 2011, Pages 53-59

  Ueoka, Yoshinori ^a   Tomotake, Masahito ^a,d   Tanaka, Tsunehiko ^a,d   Kaneda, Yasuhiro ^b,d   Taniguchi, Kyoko ^a,d   Nakataki, Masahito ^a,d   Numata, Shusuke ^a,d   Tayoshi, Shinya ^a,d   Yamauchi, Ken ^a,d   Sumitani, Satsuki ^a,d   Ohmori, Takashi ^a,d   Ueno, Shu ichi ^c,d   Ohmori, Tetsuro ^a,d  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Iwaki Clinic   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NONE

Author keywords

Cognitive function; Quality of life; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; SCHIZOPHRENIA; SYMPTOMATOLOGY; VERBAL MEMORY;

ADULT; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 78650960902     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.08.018     Document Type: Article

References (41)

1. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry 1993, (Suppl 22):39-44.
2. Addington J., Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5year follow-up study. Schizophr Res 2000, 44:47-56.
3. Aki H., Tomotake M., Kaneda Y., Iga J., Kinouchi S., Shibuya-Tayoshi S., et al. Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia. Psychiatry Res 2008, 158:19-25.
4. Andreasen N.C. The scale for the assessment of negative symptoms (SANS) 1983, The University of Iowa, Iowa.
5. Andreasen N.C. The scale for the assessment of positive symptoms (SAPS) 1984, The University of Iowa, Iowa.
6. Bozikas V.P., Kosmidis M.H., Kafantari A., Gamvrula K., Vasiliadou E., Petrikis P., et al. Community dysfunction in schizophrenia: rate-limiting factors. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:463-470.
7. Breier A., Schreiber J.L., Dyer J., Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991, 48:239-246.
8. Browne S., Roe M., Lane A., Gervin M., Morris M., Kinsella A., et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996, 94:118-124.
9. Dickerson F.B., Ringel N.B., Parente F. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 1998, 98:124-127.
10. Fitzgerald P.B., Williams C.L., Corteling N., Filia S.L., Brewer K., Adams A., et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 2001, 103:387-392.
11. George R.M., Chaturvedi S.K., Murali T., Gopinath P.S., Rao S. Cognitive deficits in relation to quality of life in chronic schizophrenics. NIMHANS J 1996, 14:1-5.
12. Gold J.M. Cognitive deficits as teatment targets in schizophrenia. Schizophr Res 2004, 72:21-28.
13. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996, 153:321-330.
14. Heinrichs D.W., Halton T.E., Carpenter W.T. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984, 10:388-398.
15. Heinrichs D.W., Halton T.E., Carpenter W.T. The quality of life scale 2001, Seiwa Pub, Tokyo.
16. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficits in schizophrenia; a quantitative review of the evidence. Neuropsychology 1998, 12:426-445.
17. Ho B.C., Nopoulos P., Flaum M., Arndt S., Andreasen N.C. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998, 155:1196-1201.
18. Hofer A., Niedermayer B., Kemmler G., Rettenbacher M.A., Trebo E., Widschwendter C.G., et al. Cognitive impairment in schizophrenia: clinical ratings are not a suitable alternative to neuropsychological testing. Schizophr Res 2007, 92:126-131.
19. Hofer A., Rettenbacher M.A., Widschwendter C.G., Kemmler G., Hummer M., Fleischhacker W.W. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur Arch Psychiatry Clin Neurosci 2006, 256:246-255.
20. Inagaki A., Inada T. Dose equivalence of psychotropic drugs. Part 4. Dose equivalence of novel antipsychotics: aripiprazole. Jpn J Clin Psychopharmacol 2006, 9:249-258. (in Japanese).
21. Inada T. Evaluation and diagnosis of drug-induced extrapyramidal symptoms: commentary on the DIEPSS and guide to its usage 1996, Seiwa Pub, Tokyo, (in Japanese).
22. Kaneda Y., Fujii A., Ohmori T. Psychometric properties of the Japanese version of the Calgary Depression Scale for Schizophrenics. J Nerv Ment Dis 2000, 188:237-239.
23. Kaneda Y., Sumiyoshi T., Keefe R.S.E., Ishimoto Y., Numata S., Ohmori T. Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci 2007, 6:602-609.
24. Kaneda Y., Sumiyoshi T., Nakagome K., Numata S., Tanaka T., Ueoka Y., et al. The brief assessment of cognition in schizophrenia Japanese version (BACS-J). Seishin Igaku. Clin Psychiatry 2008, 50(9):913-917. (in Japanese).
25. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
26. Kay S.R., Opler L.A., Fiszbein A. Positive and negative syndrome scale (PANSS) rating manual 1991, Seiwa Pub, Tokyo.
27. Keefe R.S.E., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., Coughenour L. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004, 68:283-297.
28. Keefe R.S.E., Poe M., Walker T.M., Harvey P.D. The relationship of the brief assessment of cognition in schizophrenia (BACS) to functional capacity and real-world functional outcome. J Clin Exp Neuropsychol 2006, 28:260-269.
29. Kraus M.S., Keefe R.S.E. Cognition as an outcome measure in schizophrenia. Br J Psychiatry 2007, 191(suppl.50):s46-s51.
30. Matsui M., Sumiyoshi T., Arai H., Higuchi Y., Kurachi M. Cognitive functioning related to quality of life in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:280-287.
31. Narvaez J.M., Twamley E.W., McKibbin C.L., Heaton R.K., Patterson T.L. Subjective and objective quality of life in schizophrenia. Schizophr Res 2008, 98:201-208.
32. Norman R.M.G., Malla A.K., Mclean T., Voruganti L.P.N., Cortese L., McIntosh E., et al. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and Quality of Life Scale. Acta Psychiatr Scand 2000, 102:303-309.
33. Ritsner M.S. Predicting quality of life impairment in chronic schizophrenia from cognitive variables. Qual Life Res 2007, 16:929-937.
34. Rocca P., Bellino S., Calvarese P., Marchiaro L., Patria L., Rasetti R., et al. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry 2005, 46:304-310.
35. Savilla K., Kettler L., Galletly C. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust N Z J Psychiatry 2008, 42:496-504.
36. Smith T.E., Hull J.W., Goodman M., Hedayat-Harris A., Willson D.F., Israel L.M., et al. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 1999, 187:102-108.
37. Strejilevich S.A., Palatnik A., Avila R., Bustin J., Cassone J., Figueroa S., et al. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics. Psychiatry Res 2005, 133:277-280.
38. Tomotake M., Kaneda Y., Iga J., Kinouchi S., Sumiko T., Motoki I., et al. Subjective and objective measures of quality of life have different predictors for people with schizophrenia. Psychol Rep 2006, 99:477-487.
39. Yamauchi K., Aki H., Tomotake M., Iga J., Numata S., Motoki I., et al. Predictors of subjective and objective quality of life in outpatient with schizophrnia. Psychiatry Clin Neurosci 2008, 62:404-411.
40. Wegener S., Redoblado-Hodge M.A., Lucas S., Fitzgerald D., Harris A., Brennan J. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust N Z J Psychiatry 2005, 39:87-92.
41. Xiang Y.T., Weng Y.Z., Leung C.M., Tang W.K., Ungvari G.S. Impact of sociodemographic and clinical factors on subjective quality of life in schizophrenia patients in Beijing, China. J Nerv Ment Dis 2007, 195(10):853-856.